Key result
Concomitant overweight in patients with chronic heart failure and moderately reduced or preserved ejection fraction increased the risk of the cumulative cardiovascular endpoint (HR 1.46).
Why the study?
To investigate the obesity paradox by assessing the impact of overweight and abdominal obesity on prognosis in CHF patients with moderately reduced or preserved LVEF.
Does overweight or obesity affect the prognosis of patients with chronic heart failure with moderately reduced or preserved LVEF?
Cohort (n=314)
Open-label
Does overweight or obesity affect the prognosis of patients with chronic heart failure with moderately reduced or preserved LVEF?
Hazard Ratio: 1.46 (95% CI 1.1–2.2)
p-value: p=<0.05
In patients with HFmrEF and HFpEF, overweight is associated with a higher risk of adverse cardiovascular events and rehospitalization compared to class I obesity, supporting the existence of an obesity paradox.
Overweight tied to higher event risk than mild obesity in HFmrEF/HFpEF; supports obesity paradox but leaves clinical implications open.
Aim. To investigate the obesity paradox by studying the impact of overweight and abdominal obesity on the prognosis in chronic heart failure (CHF) patients with moderately reduced or preserved left ventricular ejection fraction (LVEF) by five-year follow-up results. Materials and methods. A prospective, open, parallel-group study included 314 CHF patients with moderately reduced or preserved LVEF, average age was 65.3 ± 11.2 years. Group 1 – 66 patients with normal weight; Group 2 – 67 overweight patients; Group 3 – 90 patients with I degree abdominal obesity; Group 4 – 91 subjects with II–III degrees of obesity. Adverse cardiovascular events (CVEs) were studied as a cumulative endpoint, cardiovascular death, and rehospitalization due to decompensated CHF. Results. It has been found that excess body weight (overweight and I–III degrees of abdominal obesity) did not affect the prevalence and spectrum of adverse CVEs in CHF patients with moderately reduced and preserved LVEF. In overweight patients, compared to I degree obesity group, the incidence of cumulative end point (by 15.4 %; χ2 = 3.95, p < 0.05) and cases of re-hospitalization (by 19.0 %; χ2 = 5.6, p < 0.05) were more often observed. Concomitant overweight was associated with an increased risk for faster onset of the cumulative end point (HR 1.46, 95 % CI 1.1–2.2, p < 0.05) and re-hospitalization (HR 1.53, 95 % CI 1.1–2.4, p < 0.05). Conclusions. The presence of excess body weight (overweight and I–III degrees of abdominal obesity) did not affect the prevalence and spectrum of adverse CVEs in CHF patients with moderately reduced and preserved LVEF during the five-year follow-up. In the presence of overweight, in comparison with I degree abdominal obesity, the incidence of cumulative end point and re-hospitalization due to the disease decompensation were more often observed, which could be evidence for the existence of the obesity paradox. The most adverse effect on the prognosis in CHF patients with moderately reduced and preserved LVEF caused by concomitant overweight, in the presence of which, there was a significant increase in the risk for more faster onset of cumulative end point and re-hospitalization due to decompensation of the disease.
No takes yet. Share an insight, caveat, or question.
Bidzilya et al. (2023) conducted a cohort in Chronic heart failure with moderately reduced or preserved ejection fraction (n=314). Overweight vs. Other BMI groups was evaluated on Cumulative cardiovascular endpoint (HR 1.46, 95% CI 1.1-2.2, p=<0.05). Concomitant overweight in patients with chronic heart failure and moderately reduced or preserved ejection fraction increased the risk of the cumulative cardiovascular endpoint (HR 1.46).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: